INTERNATIONAL PATENT: TESSERACT MEDICINES US, LLC FILES APPLICATION FOR "KRAS-TARGETING COVALENT-INDUCED DRUG CONJUGATES COMPRISING A TUBULIN INHIBITOR PAYLOAD"

GENEVA, March 31 -- TESSERACT MEDICINES US, LLC (365 Boston Post RoadSudbury, Massachusetts 01776) filed a patent application (PCT/US2025/046995) for "KRAS-TARGETING COVALENT-INDUCED DRUG CONJUGATES COMPRISING A TUBULIN INHIBITOR PAYLOAD" on Sep 18, 2025. With publication no. WO/2026/064527, the details related to the patent application was published on Mar 26, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CASTRO, Alfredo C. (c/o Tesseract Medicines US, LLC365 Boston Post RoadSudbury, Massachusetts 01776), CALANDRA, Nicholas (c/o Tesseract Medicines US, LLC365 Boston Post RoadSudbury, Mass...